Plus Therapeutics board authorizes $500K share repurchase program

PLUS THERAPEUTICS, INC.

Board approved repurchase of up to $500,000 of common stock over 12 months.
Repurchases may be made on open market or privately, subject to lender consent.
Company not obligated to buy any shares; program can be discontinued at any time.

item 8.01

PLUS THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-267279

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.